Reduced synaptic function of Kainate receptors in the insular cortex of Fmr1 Knock-out mice

Mol Brain. 2018 Sep 21;11(1):54. doi: 10.1186/s13041-018-0396-1.

Abstract

Fragile X syndrome is caused by the loss of fragile X mental retardation protein (FMRP). Kainate receptor (KAR) is a subfamily of ionotropic glutamate receptors (iGluR) that acts mainly as a neuromodulator of synaptic transmission and neuronal excitability. However, little is known about the changes of synaptic KAR in the cortical area of Fmr1 KO mice. In this study, we performed whole-cell patch-clamp recordings from layer II/III pyramidal neurons in the insular cortex of Fmr1 KO mice. We found that KARs mediated currents were reduced in Fmr1 KO mice. KARs were mainly located in the synaptosomal fraction of the insular cortex. The abundance of KAR subunit GluK1 and GluK2/3 in the synaptosome was reduced in Fmr1 KO mice, whereas the total expressions of these KARs subunits were not changed. Finally, lack of FMRP impairs subsequent internalization of surface GluK2 after KAR activation, while having no effect on the surface GluK2 expression. Our studies provide evidence indicating that loss of FMRP leads to the abnormal function and localization of KARs. This finding implies a new molecular mechanism for Fragile X syndrome.

Keywords: FMRP; Fragile X syndrome; GluK1; GluK2; Insular cortex; Internalization; Kainate receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cells, Cultured
  • Cerebral Cortex / metabolism*
  • Electric Stimulation
  • Endocytosis
  • Excitatory Postsynaptic Potentials
  • Fragile X Mental Retardation Protein / metabolism*
  • Ion Channel Gating
  • Male
  • Mice, Knockout
  • Neurons / metabolism
  • Protein Subunits / metabolism
  • Pyramidal Cells / metabolism
  • Receptors, Kainic Acid / metabolism*
  • Subcellular Fractions / metabolism
  • Synapses / metabolism*
  • Synaptosomes / metabolism

Substances

  • Fmr1 protein, mouse
  • Protein Subunits
  • Receptors, Kainic Acid
  • Fragile X Mental Retardation Protein

Grants and funding